Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9537

CN(C)O.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL5181317 0.94
SCHEMBL137063 0.93
SCHEMBL5573210 0.93
Hydroxyamine SCHEMBL28198486 0.88
Hydrochloric Acid SCHEMBL27939969 0.88
SCHEMBL23120283 0.86
SCHEMBL11030471 0.86
Fluoride SCHEMBL3889688 0.86
Methane SCHEMBL5164087 0.86
SCHEMBL31337323 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5803 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025093057-A1 METHOD FOR PREPARING METARAMINOL BITARTRATE 武汉武药制药有限公司 2025-05-08 WO claimed
CN-119930447-A Preparation method of meta-hydroxylamine bitartrate 武汉武药制药有限公司 2025-05-06 CN claimed
CN-119638595-A Method for preparing dimethylol amine hydrochloride from waste liquid of methoxyamine hydrochloride production 上海鲲博玖瑞医药科技发展有限公司 2025-03-18 CN claimed
CN-118063337-B Preparation method of (S) -3-amino-2-pentanone hydrochloride 绵阳师范学院 2025-01-28 CN claimed
CN-118702619-A Synthesis method of N-methoxy-N, 1-dimethylpiperidine-4-carboxamide 杭州福斯特药业有限公司 2024-09-27 CN claimed
WO-2024151930-A1 PI3K INHIBITORS AND METHODS OF MAKING AND USING THE SAME RELAY THERAPEUTICS, INC. (US) 2024-07-18 WO claimed
CN-117739256-B Corrosion-resistant and anti-aging gas bomb and manufacturing method and application thereof 沈阳欧施盾新材料科技有限公司 2024-07-12 CN claimed
CN-118221665-A Methods and intermediates for preparing soluble guanylate cyclase stimulators 赛克里翁治疗有限公司 2024-06-21 CN claimed
CN-118184645-A Methods and intermediates for preparing soluble guanylate cyclase stimulators 赛克里翁治疗有限公司 2024-06-14 CN claimed
CN-115784857-B 4-Fluorophenyl cyclopropyl ketone-14C and preparation method thereof 长沙贝塔医药科技有限公司 2024-05-24 CN claimed
CN-103159668-A 2-hydroxy-4-oxo-2-butenoic acid compound and pharmaceutical application thereof TIANJIN INT JOINT ACADEMY BIOTECHNOLOGY & MEDICINE 2013-06-19 CN claimed
CN-101519592-B Anisotropic silicon etchant composition HAYASHI PURE CHEMICAL IND LTD 2013-06-05 CN claimed
US-20090218542-A1 ANISOTROPIC SILICON ETCHANT COMPOSITION HAYASHI PURE CHEMICAL IND, LTD. (JP) 2009-09-03 US claimed
CN-101519592-A Anisotropic silicon etchant composition HAYASHI PURE CHEMICAL IND LTD 2009-09-02 CN claimed
EP-1868604-A2 REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-12-26 EP claimed
WO-2007117482-A2 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-10-18 WO claimed
US-20070175862-A1 Anisotropic etching agent composition used for manufacturing of micro-structures of silicon and etching method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-08-02 US claimed
WO-2006078942-A2 REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2006-07-27 WO claimed
EP-1626438-A2 Anisotropic etching agent composition used for manufacturing of micro-structures of silicon and etching method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-02-15 EP claimed
WO-2004080979-A1 NOVEL 3-(2-AMINO-4-PYRIMIDINYL)-4-HYDROXYPHENYL KETONE DERIVATIVES LG LIFE SCIENCES LTD. (KR) 2004-09-23 WO claimed